Immune to Cancer: The CRI Blog
-
FDA Approves Blood Test to Screen for Colon Cancer
People living with colorectal cancer, their families, caregivers, and doctors were given a glimmer of hope on… -
Why You Should Leave CRI in Your Will
There are many distinct ways to generously give to the Cancer Research Institute (CRI) and help propel… -
Omar Ghaffar Breaks Golf World Record and Raises Over $20,000 for CRI
Illinois-based Omar Ghaffar loves golf and is passionate about raising awareness and supporting CRI’s mission. In the… -
UV Safety Awareness Month: Why the Future is Bright for Melanoma Immunotherapies
As the summer peaks and people around the U.S. and the world spend more time outside to… -
Immune Cell Triads Unveil a Critical Role in Fighting Solid Tumors
The Cancer Research Institute (CRI) is excited to share the latest study from CRI Lloyd J. Old… -
July is Sarcoma Awareness Month – Here’s What You Need to Know
Sarcomas are a complex type of cancer that can trick the body into thinking the tumor is… -
10 Attractions to Visit in and around Washington, D.C. While Attending CICON24
The eighth annual CRI-ENCI Cancer Immunotherapy Conference (CICON24) kicks off on September 8 in National Harbor, Maryland…. -
Journey Through the Highlights of the 12th Annual Cancer Immunotherapy Month™
Each June, CRI invites its global community of scientists, caretakers, patients, and more to take part in… -
FDA approves EPKINLY® for relapsed or refractory follicular lymphoma
June 26, 2024, marked a milestone for patients suffering from follicular lymphoma. The FDA approved Genmab’s epcoritamab-bysp…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.